Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

Changing Frugal Eating Habits – How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending

By Vandana Singh
April 22, 9:21 AM
Discover how GLP-1 drugs reshape consumer spending in food industries. Novo Nordisk's Wegvoy and Eli Lilly's Zepbound gain traction, altering dining habits.

CAVA

Read More
2 minute read
  • Biotech
  • General
  • News

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

By Benzinga Newsdesk
April 22, 8:44 AM
HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development

HTCR

Read More
2 minute read
  • Biotech
  • General
  • News

Veracyte’s New Study Shows The Decipher Prostate Test Is Prognostic For Prostate Cancer Progression Among Patients Undergoing Active Surveillance

By Benzinga Newsdesk
April 22, 8:42 AM
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer,

VCYT

Read More
2 minute read
  • Biotech
  • General
  • News

Waters Accelerates The Development Of Gene-based Therapeutics With New GTxResolve Premier SEC Columns

By Benzinga Newsdesk
April 22, 8:15 AM
New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.Reduces problematic non-specific binding,

WAT

Read More
2 minute read
  • Biotech
  • General
  • News

AmeriServ Financial Reaches Cooperation Agreement With Significant Shareholder SB Value Partners, L.P.

By Benzinga Newsdesk
April 22, 8:10 AM
AmeriServ Financial, Inc. (NASDAQ:ASRV) ("AmeriServ" or the "Company") today announced that it has reached a cooperation agreement ("Cooperation Agreement") with SB Value Partners, L.P. ("SBV"), which owns approximately

ASRV

Read More
2 minute read
  • Biotech
  • General
  • News

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications Highlighting Natera’s Technology In The Scientific Literature.

By Benzinga Newsdesk
April 22, 8:08 AM
Demonstrates commitment to generating real-world clinical evidence to change disease management and improve patient outcomesNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today

NTRA

Read More
1 minute read
  • Biotech
  • General
  • News

Enlivex Announces Dosing Of First Two Patients In Its Randomized, Controlled Phase I/II Trial Evaluating Allocetra In Patients With Knee Osteoarthritis

By Benzinga Newsdesk
April 22, 8:05 AM
 Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company")))), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first two patients have been dosed in the Company's

ENLV

Read More
2 minute read
  • Biotech
  • General
  • News

Corcept Announces Results From Open-Label Portion Of Pivotal Phase 3 GRACE Trial In Patients With Cushing’s Syndrome

By Benzinga Newsdesk
April 22, 8:03 AM
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by

CORT

Read More
1 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • Market-Moving Exclusives
  • News

EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent

By Vandana Singh
April 22, 8:00 AM
Adial Pharmaceuticals' genetic diagnostic patent, expanding treatment for alcohol and drug dependencies. CEO highlights the significance.

ADIL

Read More
2 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • News

Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

By Vandana Singh
April 22, 7:00 AM
Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.

PSTV

Posts pagination

Previous 1 … 58 59 60 … 733 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service